A study led by researchers at the National Drug and Alcohol Research Centre (NDARC) outlines the profiles and circumstances of 43 deaths related to LSD or psilocybin (commonly known as magic mushrooms) in Australia between 2000 and 2023.
Concerns that take-home naloxone (THN) training may lead to riskier drug use, as a form of overdose risk compensation, remain a substantial barrier to training implementation.
Non-prescribed use of pharmaceutical stimulants, such as Ritalin or dexamphetamine, for cognitive or physical enhancement and recreation is a growing concern in Australia and internationally.
This study aimed to examine buprenorphine compared with methadone in the treatment of opioid dependence across a wide range of primary and secondary outcomes.
This bulletin examines health (mental and physical) and health service access among two samples of people who use illicit drugs: people who inject drugs, and people who use ecstasy and/or other illicit stimulants.
This study aimed to determine the comparative effectiveness of postdischarge use of varenicline versus prescription nicotine replacement therapy (NRT) patches for the prevention of recurrent cardiovascular events and mortality.